Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
CSL Behring is a global biotherapeutics leader that discovers, develops, and delivers innovative therapies for serious and rare diseases in immunology, hematology, cardiovascular, metabolic, respiratory, and transplant areas. The company uses plasma fractionation, recombinant protein technology, and cell and gene therapy to address unmet medical needs and improve patient lives.
Parse Score